Viewing Study NCT01314105


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-26 @ 2:08 AM
Study NCT ID: NCT01314105
Status: COMPLETED
Last Update Posted: 2025-02-13
First Post: 2011-03-08
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer
Sponsor: Boehringer Ingelheim
Organization: